Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,219 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

RAT-HEMATO : Return to Work After Malignant Hemopathy

NCT06262789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Angers University hospital Angers, France
  • Brest University Hospital, Morvan Site Brest, France
  • Caen University hospital Caen, France
  • Rennes University Hospital, Pontchaillou site Rennes, France
View Trial Details
Recruiting

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

NCT07249346

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT05237986

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children s Hospital of Los Angeles Los Angeles, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Seattle Children s Hospital Seattle, Washington, United States
View Trial Details
Recruiting

CIML NK Cells With Venetoclax for AML

NCT06152809

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Hematologic Diseases, +6 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788

Conditions
AML, AML With Mutated NPM1, Acute Leukemia, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Health - Bowyer Oncology Center Los Angeles, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
View all 45 locations
View Trial Details
Recruiting

ALL Backbone in AYAs

NCT07227584

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions